ClinicalTrials.govpublic full text
Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
chronic myelomonocytic leukemia-0, chronic myelomonocytic leukemia-1, chronic myelomonocytic leukemia-2, myelodysplastic syndrome, recurrent chronic myelomonocytic leukemia, recurrent myelodysplastic syndrome, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 807563
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.